Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Background: Fluticasone furoate is a new enhanced‐affinity glucocorticoid with a unique combination of pharmacodynamic and physicochemical properties suitable for topical activity. Methods: In this multicentre, randomized, double‐blind, placebo‐controlled, parallel‐group study, patients [adults and adolescents ≥12 years of age with seasonal allergic rhinitis (SAR)] received once‐daily (od) treatment for 2 weeks with either fluticasone furoate nasal spray 110 μg (n = 141) or placebo nasal spray (n = 144) administered in a unique, side‐actuated device. Efficacy measures included total nasal symptom score (TNSS) and total ocular symptom score (TOSS). Patients also reported their overall response to therapy and rated their quality of life using the Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ). Results: Fluticasone furoate significantly improved the mean change from baseline in daily reflective TNSS compared with placebo (treatment difference of −1.757; P < 0.001). Fluticasone furoate was also significantly more effective in improving the morning predose instantaneous TNSS (treatment difference of −1.898; P < 0.001) and daily reflective TOSS (treatment difference of −0.741; P = 0.001). A significant treatment effect was observed as early as day 1. Compared with placebo‐treated patients, fluticasone furoate‐treated patients showed significantly greater improvements in overall evaluation of response to therapy (P < 0.001), as well as in overall RQLQ score (P < 0.001). Fluticasone furoate was well tolerated. Conclusion: Fluticasone furoate nasal spray 110 μg od was effective in improving the nasal symptoms of SAR. It also produced significant improvements in ocular symptoms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Allergic Rhinitis and Its Impact on Asthma
Bousquet, J., van Cauwenberge, P., & Khaltaev, N. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.118891 · Cited by 3,588
Dykewicz, M. S., Fineman, S., Skoner, D. P., Nicklas, R., Lee, R., Blessing-Moore, J., Li, J. T., Bernstein, I. L., Berger, W., Spector, S., et al. (1998) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)63155-9 · Cited by 652
Weiner, J. M., Abramson, M. J., & Puy, R. M. (1998) · BMJ · doi:10.1136/bmj.317.7173.1624 · Cited by 527 · cited 1×
“In a metaanalysis of studies comparing INS with antihistamines, INS treatment was shown to reduce ocular symptoms as effectively as oral antihistamines (15).”
BackgroundNasal obstruction as a risk factor for sleep-disordered breathing
Young, T., Finn, L., & Kim, H. (1997) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(97)70124-6 · Cited by 505
Economic impact and quality-of-life burden of allergic rhinitis
Schoenwetter, W. F., Dupclay, L., Appajosyula, S., Botteman, M. F., & Pashos, C. L. (2004) · Current Medical Research and Opinion · doi:10.1185/030079903125003053 · Cited by 256
Cited by
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*
Bousquet, J., Khaltaev, N., Cruz, A. A., Denburg, J., Fokkens, W. J., Togias, A., Zuberbier, T., Baena‐Cagnani, C. E., Canonica, G. W., Van Weel, C., et al. (2008) · Allergy · doi:10.1111/j.1398-9995.2007.01620.x · Cited by 4,729
Self-citationPaediatric rhinitis: position paper of the European Academy of Allergy and Clinical Immunology
Roberts, G., Xatzipsalti, M., Borrego, L. M., Custovic, A., Halken, S., Hellings, P. W., Papadopoulos, N. G., Rotiroti, G., Scadding, G., Timmermans, F., et al. (2013) · Allergy · doi:10.1111/all.12235 · Cited by 416
MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis
Bousquet, J., Schünemann, H. J., Hellings, P. W., Arnavielhe, S., Bachert, C., Bedbrook, A., Bergmann, K.-C., Bosnic-Anticevich, S., Brozek, J., Calderon, M., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.03.025 · Cited by 168
Self-citationThe Effect of Combined Medical Treatment on Quality of Life in Persistent Allergic Rhinitis
Tatar, E. Ç., Sürenoğlu, Ü. A., Özdek, A., Saylam, G., & Korkmaz, H. (2013) · Indian Journal of Otolaryngology and Head & Neck Surgery · doi:10.1007/s12070-012-0486-9 · Cited by 11
Metadata
- Authors
- Fokkens, W. J., Jogi, R., Reinartz, S., Sidorenko, I., Sitkauskiene, B., Van Oene, C., Faris, M. A., Ellsworth, A., & Caldwell, M. F.
- Venue
- Allergy
- Publisher
- Wiley
- Published
- 2007-08-04
- Volume
- 62
- Issue
- 9
- Pages
- 1078-1084
- ISSN
- 0105-4538 (ISSN-L)
- 1398-9995
- OpenAlex
- W2031208354
- Cited by
- 103
- References
- 5
- FWCI
- 8.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.